Literature DB >> 21398620

Novel murine model of chronic granulomatous lung inflammation elicited by carbon nanotubes.

Isham Huizar1, Anagha Malur, Yasmeen A Midgette, Cindy Kukoly, Pengyu Chen, Pu Chun Ke, Ramakrishna Podila, Apparao M Rao, Christopher J Wingard, Larry Dobbs, Barbara P Barna, Mani S Kavuru, Mary Jane Thomassen.   

Abstract

Lung granulomas are associated with numerous conditions, including inflammatory disorders, exposure to environmental pollutants, and infection. Osteopontin is a chemotactic cytokine produced by macrophages, and is implicated in extracellular matrix remodeling. Furthermore, osteopontin is up-regulated in granulomatous disease, and osteopontin null mice exhibit reduced granuloma formation. Animal models currently used to investigate chronic lung granulomatous inflammation bear a pathological resemblance, but lack the chronic nature of human granulomatous disease. Carbon nanoparticles are generated as byproducts of combustion. Interestingly, experimental exposures to carbon nanoparticles induce pulmonary granuloma-like lesions. However, the recruited cellular populations and extracellular matrix gene expression profiles within these lesions have not been explored. Because of the rapid resolution of granulomas in current animal models, the mechanisms responsible for persistence have been elusive. To overcome the limitations of previous models, we investigated whether a model using multiwall carbon nanoparticles would resemble chronic human lung granulomatous inflammation. We hypothesized that pulmonary exposure to multiwall carbon nanoparticles would induce granulomas, elicit a macrophage and T-cell response, and mimic other granulomatous disorders with an up-regulation of osteopontin. This model demonstrates: (1) granulomatous inflammation, with macrophage and T-cell infiltration; (2) resemblance to the chronicity of human granulomas, with persistence up to 90 days; and (3) a marked elevation of osteopontin, metalloproteinases, and cell adhesion molecules in granulomatous foci isolated by laser-capture microdissection and in alveolar macrophages from bronchoalveolar lavage. The establishment of such a model provides an important platform for mechanistic studies on the persistence of granuloma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398620      PMCID: PMC5460893          DOI: 10.1165/rcmb.2010-0401OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  44 in total

Review 1.  T-lymphocytes and cytokines in sarcoidosis.

Authors:  Carlo Agostini; Alessia Meneghin; Gianpietro Semenzato
Journal:  Curr Opin Pulm Med       Date:  2002-09       Impact factor: 3.155

2.  Direct visual instillation as a method for efficient delivery of fluid into the distal airspaces of anesthetized mice.

Authors:  Xiao Su; Mark Looney; Laurent Robriquet; Xiaohui Fang; Michael A Matthay
Journal:  Exp Lung Res       Date:  2004-09       Impact factor: 2.459

3.  Distinct roles of osteopontin fragments in the development of the pulmonary involvement in sarcoidosis.

Authors:  K Maeda; K Takahashi; F Takahashi; N Tamura; M Maeda; S Kon; T Uede; Y Fukuchi
Journal:  Lung       Date:  2001       Impact factor: 2.584

4.  Osteopontin involvement in granuloma formation and in the severity of Paracoccidioides brasiliensis infection.

Authors:  Angela Satie Nishikaku; Renata Scavone; Raphael Fagnani Sanchez Molina; Bernardo Paulo Albe; Cláudia Da Silva Cunha; Eva Burger
Journal:  Med Mycol       Date:  2009       Impact factor: 4.076

Review 5.  The role of osteopontin in lung disease.

Authors:  Anthony O'Regan
Journal:  Cytokine Growth Factor Rev       Date:  2003-12       Impact factor: 7.638

6.  Sarcoidosis, firefighters sarcoidosis, and World Trade Center "sarcoid-like" granulomatous pulmonary disease.

Authors:  Albert Miller
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

7.  Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF.

Authors:  M T Henry; K McMahon; A J Mackarel; K Prikk; T Sorsa; P Maisi; R Sepper; M X Fitzgerald; C M O'Connor
Journal:  Eur Respir J       Date:  2002-11       Impact factor: 16.671

Review 8.  Recent progress in the genetics of Wegener's granulomatosis and Churg-Strauss syndrome.

Authors:  Stefan Wieczorek; Julia U Holle; Jörg T Epplen
Journal:  Curr Opin Rheumatol       Date:  2010-01       Impact factor: 5.006

Review 9.  Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus?

Authors:  A A Shvedova; E R Kisin; D Porter; P Schulte; V E Kagan; B Fadeel; V Castranova
Journal:  Pharmacol Ther       Date:  2008-12-06       Impact factor: 12.310

10.  Granulomatous infectious diseases associated with tumor necrosis factor antagonists.

Authors:  R S Wallis; M S Broder; J Y Wong; M E Hanson; D O Beenhouwer
Journal:  Clin Infect Dis       Date:  2004-04-15       Impact factor: 9.079

View more
  41 in total

1.  A carbon nanotube toxicity paradigm driven by mast cells and the IL-₃₃/ST₂ axis.

Authors:  Pranita Katwa; Xiaojia Wang; Rakhee N Urankar; Ramakrishna Podila; Susana C Hilderbrand; Robert B Fick; Apparao M Rao; Pu Chun Ke; Christopher J Wingard; Jared M Brown
Journal:  Small       Date:  2012-07-06       Impact factor: 13.281

Review 2.  Occupational causes of sarcoidosis.

Authors:  Kira L Newman; Lee S Newman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-04

3.  Peroxisome Proliferator-activated Receptor-γ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model.

Authors:  Anagha Malur; Arjun Mohan; Robert A Barrington; Nancy Leffler; Amrita Malur; Barbara Muller-Borer; Gina Murray; Kim Kew; Chuanzhen Zhou; Josh Russell; Jacob L Jones; Christopher J Wingard; Barbara P Barna; Mary Jane Thomassen
Journal:  Am J Respir Cell Mol Biol       Date:  2019-08       Impact factor: 6.914

Review 4.  Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes.

Authors:  Jie Dong; Qiang Ma
Journal:  Nanotoxicology       Date:  2019-09-19       Impact factor: 5.913

Review 5.  Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans.

Authors:  Eileen D Kuempel; Marie-Claude Jaurand; Peter Møller; Yasuo Morimoto; Norihiro Kobayashi; Kent E Pinkerton; Linda M Sargent; Roel C H Vermeulen; Bice Fubini; Agnes B Kane
Journal:  Crit Rev Toxicol       Date:  2016-08-18       Impact factor: 5.635

6.  Alveolar Macrophage ABCG1 Deficiency Promotes Pulmonary Granulomatous Inflammation.

Authors:  Matthew McPeek; Anagha Malur; Debra A Tokarz; Kvin Lertpiriyapong; Kymberly M Gowdy; Gina Murray; Christopher J Wingard; Michael B Fessler; Barbara P Barna; Mary Jane Thomassen
Journal:  Am J Respir Cell Mol Biol       Date:  2019-09       Impact factor: 6.914

7.  Role of p53 in the chronic pulmonary immune response to tangled or rod-like multi-walled carbon nanotubes.

Authors:  Katherine S Duke; Elizabeth A Thompson; Mark D Ihrie; Alexia J Taylor-Just; Elizabeth A Ash; Kelly A Shipkowski; Jonathan R Hall; Debra A Tokarz; Mark F Cesta; Ann F Hubbs; Dale W Porter; Linda M Sargent; James C Bonner
Journal:  Nanotoxicology       Date:  2018-10-14       Impact factor: 5.913

8.  Transcriptional survey of alveolar macrophages in a murine model of chronic granulomatous inflammation reveals common themes with human sarcoidosis.

Authors:  Arjun Mohan; Anagha Malur; Matthew McPeek; Barbara P Barna; Lynn M Schnapp; Mary Jane Thomassen; Sina A Gharib
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-06       Impact factor: 5.464

9.  PPAR-gamma pathways attenuate pulmonary granuloma formation in a carbon nanotube induced murine model of sarcoidosis.

Authors:  Matthew McPeek; Anagha Malur; Debra A Tokarz; Gina Murray; Barbara P Barna; Mary Jane Thomassen
Journal:  Biochem Biophys Res Commun       Date:  2018-06-15       Impact factor: 3.575

10.  Multiwalled Carbon Nanotube Functionalization with High Molecular Weight Hyaluronan Significantly Reduces Pulmonary Injury.

Authors:  Salik Hussain; Zhaoxia Ji; Alexia J Taylor; Laura M DeGraff; Margaret George; Charles J Tucker; Chong Hyun Chang; Ruibin Li; James C Bonner; Stavros Garantziotis
Journal:  ACS Nano       Date:  2016-08-02       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.